The Board of Certification/Accreditation (BOC) provided the following statement in response to the decision by The Centers for Medicare & Medicaid Services (CMS) to terminate its approval of BOC as an accreditation organization for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) effective December 2.
BOC confirms that CMS notified BOC of its decision to immediately withdraw BOC’s status as a ‘deemed’ accrediting organization (AO) effective December 2.
BOC has sought guidance from CMS on how CMS plans to operationalize this abrupt change for BOC’s customers. CMS advised that all inquiries regarding impact on supplier Medicare enrollment should be directed to the following email: dmeaccreditation@cms.hhs.gov.
Those who value accreditation and are committed to DMEPOS product access and patient safety understand that accreditation operations cannot be abruptly halted without resulting in a negative impact on DMEPOS suppliers and the patients/beneficiaries they serve.
In response to CMS’ abrupt termination, BOC has filed Board of Certification/Accreditation International, Inc. v. Robert F. Kennedy, Jr. et al, Case No. 1:25-cv-04150-MJM, in the United States District Court of Maryland.
Since December 2, our focus has been on the DMEPOS customers most immediately impacted: new and reaccrediting facilities in the midst of completing the final requirements to confirm compliance and receive accreditation. Some of these customers were surveyed weeks prior to CMS issuing the December 2 notice of withdrawal.
BOC is dismayed by the actions of CMS, particularly with its refusal to have verbal conversations with BOC before withdrawing BOC’s deemed status. All BOC certification programs remain relevant and valid for the thousands of providers holding BOC credentials.
For more information on the CMS action, read CMS Terminates BOC’s DMEPOS Accreditation.
